Skip to content

Public FDA record

Z-0305-05: Tibial Base Plates

Recall record Z-0305-05 for Smith & Nephew Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0305-05
Company in FDA record
Smith & Nephew Inc
FDA classification date
Dec 14, 2004
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

The firm received confirmed reports of Genesis Uni Articular Inserts not locking into tibial base plates intraoperatively.

Source facts

Action
Recall notification was initiated by letter (Fed Ex) to domestic territory manager and sales representative and to international distributors (via email) on 06/21/2004 to request the return of any in stock product.
Initiated
2004-06-21
Root cause
Other
Terminated
2006-02-15
Distribution
Nationwide, 43 consignees, 17 countries: Germany, France, Australia, Italy, Switzerland, United Arab Emirates, Belgium, Japan, United Kingdom, Singapore, Spain, Taiwan. Sweden, Canada Venezuela, South Africa, and Israel.
Recall number
Z-0305-05
Recall status
Terminated
CDRH record ID
34580
FDA classified
2004-12-14
Recall event number
29816

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗